Pharmacotherapy of fungal eye infections

Bibliography

• THIELEN TL, CASTLE SS, TERRY JE: ocular infections: An overview of and treatment. Ann. Pharmacother. (2000) 34:235–245.
   PubMed Web of Science ®Google Scholar
• •Good concise review of anterior ocular infections.
   Google Scholar
• CHOI DM, GOLDSTEIN MH, SALIERNO A, DRIEBE WT: Fungal keratitis in a daily disposable soft contact lens wearer. CLAO (2001) 27:111–112.
   PubMedGoogle Scholar
• ESSMAN TF, FLYNN HW Jr., SMIDDY WD et al.: Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmol. Surg. Lasers (1997) 28:185–194.
   Google Scholar
• URBAK SE DEGN T: Fluconazole in the management of fungal ocular infections. Ophthalmologica (1994) 208:147–156.
   PubMed Web of Science ®Google Scholar
• MCDONNELL PJ, GREEN WR: Keratitis, in Mandell GL, Douglas RG Jr, Bennett JE (Eds): Principles and Practice of Infectious Diseases. New York, Churchill Livingstone (1990):981–987.
   Google Scholar
• O'DAY DM: New antifungal drugs in ophthalmology. Int. OphthalmoL (1996) 36(2):45–51.
   Google Scholar
• WEINGEIST TA, LIESEGANG TJ, GILBERT GRAND M (Eds): Fungal keratitis, in External Disease and Cornea. San Francisco, Am. Acad. Ophthalmol. (1999)
   Google Scholar
• JONES BR: Principles in the management of oculomycosis. Am. J. Ophthalmol. (1975) 79(5):719–751.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG RA: The microbiology of the eye. Ophthalmol. PhysioL Opt. (2000) 20(6):429–441.
   PubMed Web of Science ®Google Scholar
• ••Excellent review of the types of eyeinfections caused by microorganisms with classification into the various anatomical structures of the eye.
   Google Scholar
• LEMP MA, BLACKMAN HJ, KOFFLER BH: Therapy for bacterial and fungal infections. Int. Ophthalmol. Clin. (1980) 20(3):135–147.
   PubMedGoogle Scholar
• BEHRENS-BAUMANN W: Topical antimycotics in ophthalmology. Ophthalmologica (1997) 211\(Suppl. 1):33–38.
   Google Scholar
• •Good introduction to antifungal agents.
   Google Scholar
• BEHRENS-BAUMANN W: Mycosis of the and its adenexa. Dev. Ophthalmol. (1999) 32.
   Google Scholar
• ••Excellent review of the ophthalmic fungalpathogens and antifungal agents.
   Google Scholar
• O'DAY DM, STEVEN HEAD W: Advances in the management of keratomycosis and Acatithamoeba Keratitis. Cornea (2000) 19(5):681–687.
   PubMed Web of Science ®Google Scholar
• WOOD TO, WILLIFORD W: Treatment of keratomycosis with amphotericin B 0.15%. Am. J. Ophthalmol. (1976) 81(6):847–849.
   Google Scholar
• O'DAY DM, HEAD WS, ROBINSON RD et al.: Corneal penetration of topical amphotericin B and natamycin. Cun: Eye Res. (1986) 5:877–882.
   PubMed Web of Science ®Google Scholar
• PFLUGFELDER SC, FLYNN HW, ZWICKEY TA et al.: Exogenous fungal endophthalmitis. Ophthalmology (1988) 95(1):19–30.
   PubMed Web of Science ®Google Scholar
• MILLS R, GARRETT G: Pseudallescheria boydii keratitis. Aust. NZ J. Ophthalmol. (1992) 20(3):253–256.
   PubMedGoogle Scholar
• REUBEN A, ANAISSIE E, NELSON PE et al.: Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob. Agents Chemother. (1989) 33:1647–1649.
   PubMed Web of Science ®Google Scholar
• ROTOWA NA, SHADOMY HJ, SHADOMY S: In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens. Mycose (1990) 33(4):203–211.
   PubMed Web of Science ®Google Scholar
• GOLDBLUM D, FRUEH BE, S, BOHNKE M: Treatment of postkeratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea (2000) 19(6):853–856.
   PubMed Web of Science ®Google Scholar
• BENNETT JE: Antimicrobial agents. In: The Pharmacological Basis of Therapeutics, volume IL Goodman Gilman A, Rall TW, Nies AS, Taylor P (Eds). Oxford, Pergamon Press (1991):1165–1181.
   Google Scholar
• Heterocyclic compounds. In: Organic Chemistry volume I Finar IL (Ed). Harlow, Longman Group Limited (1981)847.
   Google Scholar
• SUGAR AM: Fluconazole and itraconazole: current status and prospects for antifungal therapy. Curr. OM. Top. Infect. Dis. (1993) 13:74–98.
   PubMedGoogle Scholar
• ABBASOGLU OE, HOSAL BM, SENER B, ERDEMOGLU N, GURSEL E: Penetration of topical fluconazole into human aqueous humor. Exp. Eye Res. (2001) 72:147–151.
   PubMed Web of Science ®Google Scholar
• SLAIN D, ROGERS PD, CLEARY JD, CHAPMAN SW: Intravenous itraconazole. Ann. Pharm. (2001) 35(6):720–729.
   PubMed Web of Science ®Google Scholar
• MEDOFF G, KOBAYASHI GS: Strategies in the treatment of systemic fungal infections. N Engl. I Med. (1980) 302(3):145–155.
   PubMed Web of Science ®Google Scholar
• MARTIN MJ, RAHMAN MR, JOHNSON GJ, SRINIVASAN M, CLAYTON YM: Mycotic keratitis: suspectibility to antiseptic agents. Irir Ophthalmology (1996) 19:299–302.
   Web of Science ®Google Scholar
• MEUNIER F: Alternative modalities of administering amphotericin B: current issues. J. Infect. (1994) 28\(Suppl. 1):51–56.
   Google Scholar
• Antifungal drugs. In: British National Formulary (Volume 41), British Medical, London, UK (2001).
   Google Scholar
• STERN GA, BUTTROSS M: Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology (1991) 98(6):847–53.
   PubMed Web of Science ®Google Scholar
• PINEDA R II, DOHLMAN CH: The roleof steroids in the management of Acanthamoeba keratitis, fungal keratitis, and epidemic keratoconjunctivitis. OM. (1994) 34(3):19–31.
   Google Scholar
• THYGESON P, OKUMOTO M: Keratomycosis: a preventable disease. Trans. Am. Acad. Ophthalmol Otol. (1974) 78:433–439.
   Google Scholar
• O'DAY DM, RAY WA, ROBINSON R, STEVEN HEAD W: Efficacy of antifungal agents in the cornea: Influence of corticosteroids. Invest. Ophthalmol Vis. Se (1984) 25:331–335.
   PubMed Web of Science ®Google Scholar
• ANAND A, MADHAVEN H, NEELAM, LILY T: Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. (2001) 108:326–330.
   Google Scholar
• OKHRAVI N, ADAMS ON P, LIGHTMAN S: Use of PCR in endophthalmitis. Ocul. Inimuriol (2000) 8:189–200.
   PubMed Web of Science ®Google Scholar
• WANG MX, SHEN DJ, LIU JC, PFLUGFELDER SC, ALFONSO EC, FORSTER RK: Recurrent fungal keratitis and endophthalmitis. Cornea (2000) 19:559–560.
   Web of Science ®Google Scholar
• FORSTER RK: Endophthalmitis. In: Duane Clinical Ophthalmology (CD edition). Tasman W, Jaeger EA (Eds.), Lippincott Williams, Wilkins, Philadelphia, USA (1999).
   Google Scholar
• RAHMAN MR, JOHNSON GJ, R, HOWLADER SA, MINASSIAN DC: Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br. I Ophthalmol (1998) 82:919–925.
   Google Scholar
• DENTON GW: Disinfectants and antiseptics. A. By chemical type: chlorhexidine. In: Disinfection, Sterilization and Preservation. (4th Edition). Block SS, (Ed). Lea and Febgier, Philadelphia, USA (1991):274–287.
   Google Scholar
• VAN GOOL R: The cost of treating systemic fungal infections. Drugs (2001) 61 (Suppl. 1):49–56.
   Google Scholar
• SATO Y, MIYASAKA S, SHIMADA H: Prognosis of endogenous fungal endophthalmitis and utility of Ishibashi's classification. fpri. j Ophthalmol (2001) 45:181–186.
   Web of Science ®Google Scholar
• ••Excellent article for use as a basis forclinical practice in the management of fungal endophthalmitis.
   Google Scholar
• ISHIBASHI Y: Proposed classification of of endogenous fungal. fpri. I Clin. Ophthalmol (1993) 47:845–849.
   Google Scholar